Global Supplier of High-Quality Pharmaceutical Core Ingredients & Integrated Solutions
PHMO is a global pharmaceutical ingredient supplier and manufacturer dedicated to providing high-quality active pharmaceutical ingredients (APIs), high-purity intermediates, pharmaceutical excipients and veterinary APIs to the pharmaceutical and biotechnology industries. Supported by an independent R&D center and a robust global supply network, we offer comprehensive services ranging from standard product supply to customized intermediate development, process optimization, and route design. With end-to-end control from laboratory research to commercial production, we focus on delivering high-quality core ingredients and complete process packages for key therapeutic areas such as respiratory, psychiatric, and antidepressant drugs, empowering global pharmaceutical innovation.
Our Purpose
We strive to be the most valuable partner in the global healthcare sector. Focused on your needs, we integrate robust manufacturing capabilities and technical expertise to create a safe, efficient, and firm raw material supply system, helping you reduce costs and risks, allowing you to focus on your core business for developing life-saving health therapies.
We understand that quality is the lifeblood of the pharmaceutical industry. Through rigorous quality control systems and continuous technological innovation, we ensure the provision of stable, reliable, and high-value-added products and services to our global customers.
Sustainability
Guided by our core EHS philosophy of "Safety First, Compliant Operation, and Green Sustainable Development," we fully implement ESG principles and are committed to building a comprehensive end-to-end management system. By promoting green production, ensuring occupational health, enhancing intrinsic safety, and exceeding compliance benchmarks, we earnestly fulfill our responsibilities to employees, the community, and the environment, consistently creating long-term value for both human health and sustainable ecological development.
Technology-Driven Solutions for API Innovation
We are a technology-driven innovator, leveraging dual strengths in chemical synthesis and synthetic biology. We continuously develop engineering technology platforms—including continuous flow chemistry, crystals and powders, peptides, and high-throughput screening—to enhance existing product competitiveness and accelerate new strategic product development. Supported by four GMP manufacturing sites equipped with advanced analytical instruments (e.g., Qtof, UPLC-MS, UPLC, GPC) and reactor systems from 5L to 20,000L, we handle highly challenging processes, from extreme temperatures (-110°C to >200°C) and high-pressure (>100 atm) reactions to diazomethane and non-precious metal catalysis. This comprehensive capability enables end-to-end support from lab to commercial production, driving our mission to become a global leader in pharmaceutical raw material manufacturing.
Our Business Areas
Human APIs
We offer an extensive range of high-quality human APIs manufactured in full compliance with USP, EP, and ChP standards. Our end-to-end in-house capabilities from R&D to commercial-scale production enable us to deliver reliable and compliant active pharmaceutical ingredients for a wide spectrum of therapeutic areas.
Intermediates
Our high-purity intermediates serve as essential building blocks in the synthesis of complex APIs, ensuring seamless integration into critical drug development processes. We specialize in the custom R&D and cGMP-compliant production of technically demanding intermediates.
Veterinary APIs
We specialize in the development and production of high-efficacy, low-residue veterinary APIs that adhere to rigorous international regulatory and safety requirements. Our products are manufactured in compliance with global GMP, pharmacopeia, and MRL standards.
Excipients
Our functional excipients are engineered to optimize drug performance, improve stability, enhance bioavailability, and ensure patient adherence. With a comprehensive portfolio including binders, disintegrants, solubilizers, and sustained-release agents.
Integrated Services from R&D to Commercialization
We provide end-to-end R&D and manufacturing solutions from basic materials to custom intermediates and APIs, covering route scouting, process development, analytical support, and commercial-scale production. With full in-house capabilities from lab to plant, we specialize in key therapeutic areas such as respiratory, CNS, and antidepressant drugs, delivering high-quality key materials and complete process packages to enable global pharmaceutical innovation.
Route Scouting & Design
We develop innovative, efficient, and cost-effective synthetic routes with greater IP flexibility. Through literature research, structural analysis, and mechanism simulation, we design and test 2–3 potential routes at lab scale. A comparative evaluation leads to the selection of the optimal route, balancing feasibility and economy, laying the foundation for a robust process package.
Process Development & Optimization
Using Design of Experiments (DOE), we systematically optimize critical parameters such as temperature, pressure, catalyst loading, and reaction time to improve yield and process robustness. We also integrate green chemistry principles to reduce VOC emissions and solid waste, lowering environmental impact and ensuring commercial viability.
Custom Intermediate R&D & Production
We specialize in the R&D and production of high-value, challenging chemical intermediates. From structure, purity, and capacity requirements, we develop lab-scale processes, control critical impurities, and scale up through GMP-compliant pilot and commercial lines, enabling seamless technology transfer and supply stability within a complete process package.
Analytical Support & Process Validation
Our analytical team supports all stages from preclinical to commercial, offering method development/validation, structural elucidation, impurity profiling, stability studies, and cleaning validation. During process validation, we identify CPPs, establish PARs, and define control strategies ensuring regulatory compliance and robustness of the process package for global registration.